MedTrace Logo

Incidence of Post Cystography Urinary Tract Infections in the Pediatric Population

NCT03399682 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-01-17

No results posted yet for this study

Summary

Cystography is a frequent pediatric examination, although indications have been recently restricted .

Current indications in our center are:

* The occurrence of 2 episodes of acute pyelonephritis
* or 1 episode of pyelonephritis if dilatation of the pelvic ureter\> 5 mm for male children Urinary tract infections that occurred in the month following this test are considered secondary to cystography.

However, no recent study has investigated the prevalence of urinary tract infections post cystography.

There is no recent epidemiological data on this risk of infection, especially since the management of infections has changed and aseptic precautions during retrograde cystography have evolved with most of the time coverage. antibiotic.

The main objective of this multi-center epidemiological prospective study is to perform a recent analysis of the retrograde post-cystographic urinary tract infection rate.

Material and methods:

Epidemiological, observational, multicenter, prospective study over a period from January 2018 to January 2019. No therapeutic modification will be undertaken at the end of the study.

Parents will be called one months after the exam to check if their child had a urinary infection.

Conditions

  • Urinary Infection

Interventions

DIAGNOSTIC_TEST

cystography

observationnal study

Sponsors & Collaborators

  • CH Lisieux

    collaborator UNKNOWN

  • CH Avranches

    collaborator UNKNOWN

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Kassel christophe · CHU CAEN

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-03
Primary Completion
2018-02-03
Completion
2019-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03399682 on ClinicalTrials.gov